PESCI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 10.884
EU - Europa 4.954
AS - Asia 2.599
SA - Sud America 242
AF - Africa 26
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.720
Nazione #
US - Stati Uniti d'America 10.728
SG - Singapore 1.072
IT - Italia 989
DE - Germania 892
CN - Cina 770
SE - Svezia 736
IE - Irlanda 611
RU - Federazione Russa 510
UA - Ucraina 324
HK - Hong Kong 289
GB - Regno Unito 233
BR - Brasile 218
AT - Austria 151
FR - Francia 149
ID - Indonesia 149
CA - Canada 141
FI - Finlandia 127
VN - Vietnam 95
IN - India 82
DK - Danimarca 62
TR - Turchia 44
NL - Olanda 43
BE - Belgio 34
CZ - Repubblica Ceca 27
JP - Giappone 14
ES - Italia 13
PK - Pakistan 13
IR - Iran 10
CH - Svizzera 9
RO - Romania 9
KR - Corea 8
AU - Australia 7
BD - Bangladesh 7
CL - Cile 7
IQ - Iraq 7
MX - Messico 7
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
AL - Albania 4
AR - Argentina 4
BG - Bulgaria 4
EC - Ecuador 4
GR - Grecia 4
IL - Israele 4
PA - Panama 4
SC - Seychelles 4
CO - Colombia 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
PL - Polonia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
VE - Venezuela 2
A1 - Anonimo 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 18.720
Città #
Ann Arbor 2.538
Fairfield 907
Woodbridge 862
Chandler 851
Singapore 708
Frankfurt am Main 618
Dublin 593
Houston 576
Wilmington 548
Ashburn 529
Dearborn 351
Jacksonville 341
Seattle 340
New York 308
Cambridge 291
Hong Kong 287
Princeton 240
Milan 227
Santa Clara 195
Jakarta 145
Nanjing 143
Vienna 134
Shanghai 120
Altamura 113
Lawrence 105
Beijing 73
Guangzhou 60
San Diego 59
Council Bluffs 57
Boardman 56
Lachine 56
Dong Ket 52
Helsinki 49
Nanchang 48
Fremont 42
Moscow 39
Toronto 36
Andover 33
Hebei 33
Nuremberg 33
Brussels 32
Jinan 32
Los Angeles 32
Shenyang 30
Lissone 26
Jiaxing 24
Tianjin 24
Monza 22
Brno 21
London 20
Norwalk 19
Rome 19
Falls Church 18
Hangzhou 18
Lappeenranta 18
Ottawa 17
Munich 16
São Paulo 16
Brescia 15
Mountain View 15
Ningbo 15
Changsha 14
Zhengzhou 13
Pune 12
Edmonton 11
Florence 11
Hefei 11
Beauharnois 9
Kiev 9
Kocaeli 9
Paris 9
Phoenix 9
Belo Horizonte 8
Chicago 8
Desio 8
Genoa 8
Kunming 8
Tappahannock 8
Turin 8
Auburn Hills 7
Dallas 7
Leawood 7
Newark 7
Washington 7
Amsterdam 6
Ansbach 6
Bari 6
Berlin 6
Brasília 6
Groningen 6
Montréal 6
Naples 6
Orange 6
Palermo 6
Redmond 6
Sacramento 6
Wuhan 6
Zurich 6
Auckland 5
Carate Brianza 5
Totale 13.547
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 360
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 316
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 300
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 300
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 299
Regional differences in bronchial reactivity assessed by respiratory impedance 242
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 242
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 240
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 233
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 223
Dyspnea in crackling lungs 222
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 216
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 214
Impact of traffic-related air pollution on pulmonary oxidative stress 212
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 203
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 203
Characterization of bronchiectasis in the elderly 201
Renal involvement in Churg-Strauss syndrome 199
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 199
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 198
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 197
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 195
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 195
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 194
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 191
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 191
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 191
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 190
Clinical phenotypes in adult patients with bronchiectasis 189
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 188
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 188
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 188
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 188
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 187
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 187
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 185
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 185
A 61-year-old female with chronic cough and purulent sputum 182
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 181
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 178
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 176
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 176
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 175
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 175
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 174
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 173
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 170
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 170
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 168
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 166
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 164
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 159
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 159
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 158
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 158
The management of community-acquired pneumonia in the elderly 157
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 157
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 156
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 156
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 154
COPD: maximization of bronchodilation 151
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 151
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 147
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 145
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 143
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 143
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 142
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 140
Interstitial lung diseases in a lung cancer screening trial 139
History of lung volume reduction procedures 139
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 137
Long-term macrolides in diffuse interstitial lung diseases 137
Respiratory system involvement in systemic vasculitides 134
The bronchiectasis severity index. An international derivation and validation study 134
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 134
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 133
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 132
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 127
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 126
Alveolar Diseases 125
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 125
Respiratory system involvement in ANCA-associated systemic vasculitides 123
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 123
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 120
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 119
Bronchoalveolar lavage in intensive care units 118
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 117
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 115
The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis 114
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 113
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 112
Outcome and prognostic factors during the course of primary small-vessel vasculitides 110
Cryoglobulinemia 110
Reticular Diseases 108
Respiratory System Involvement in Antineutrophil Cytoplasmic-associated Vasculitides: Clinical, pathological, radiological and therapeutic considerations 107
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 107
Cystic Diseases 107
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 106
Interferon gamma e fibrosi polmonare idiopatica 105
Surgical and endoscopic treatment for COPD: Patients selection, techniques and results 105
Totale 16.916
Categoria #
all - tutte 72.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 0 0 0 0 0 0 185 152 79
2020/20213.017 112 111 256 348 281 265 291 346 281 312 169 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.995 52 61 107 97 247 551 367 90 122 33 32 236
2024/20253.123 282 524 250 205 411 247 258 226 520 200 0 0
Totale 19.415